Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Larcher

Showing results (241-250 of 335) with videos related to

Pageof 34
Sort By:
Urologic Oncology|June 20, 2021
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02Andrea Necchi, Alberto Martini, Daniele Raggi, et al.
World Journal of Urology|October 29, 2025
Impact of patient characteristics and comorbidities on the risk of postoperative acute kidney injury: a comparative analysis of on clamp vs. off-clamp techniquesAlfonso Santangelo, Pietro Scilipoti, Giuseppe Rosiello, et al.
World Journal of Urology|February 3, 2019
Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomyZachary A Hamilton, Umberto Capitanio, Brian R Lane, et al.
European Urology Focus|August 2, 2022
Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial NephrectomyGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
European Urology Open Science|September 27, 2024
The Detrimental Effect of Metabolic Syndrome on Long-term Renal Function in Patients Undergoing Elective Partial Nephrectomy for Small Renal MassesPietro Scilipoti, Giuseppe Rosiello, Federico Belladelli, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 1, 2025
Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelinesMattia Longoni, Giorgio Brembilla, Giuseppe Rosiello, et al.
Urologic Oncology|November 26, 2021
Simplified PADUA renal (SPARE) nephrometry score validation and long-term outcomes after robot-assisted partial nephrectomyGiuseppe Rosiello, Pietro Piazza, Stefano Puliatti, et al.
World Journal of Urology|October 12, 2022
Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicityGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
The Journal of Urology|November 28, 2022
Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell CarcinomaGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
BJU International|August 19, 2014
Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective studyAlberto Abrate, Massimo Lazzeri, Giovanni Lughezzani, et al.
Pageof 34

Showing results (241-250 of 335) with videos related to

Sort By:
Pageof 34
Urologic Oncology|June 20, 2021
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02Andrea Necchi, Alberto Martini, Daniele Raggi, et al.
World Journal of Urology|October 29, 2025
Impact of patient characteristics and comorbidities on the risk of postoperative acute kidney injury: a comparative analysis of on clamp vs. off-clamp techniquesAlfonso Santangelo, Pietro Scilipoti, Giuseppe Rosiello, et al.
World Journal of Urology|February 3, 2019
Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomyZachary A Hamilton, Umberto Capitanio, Brian R Lane, et al.
European Urology Focus|August 2, 2022
Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial NephrectomyGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
European Urology Open Science|September 27, 2024
The Detrimental Effect of Metabolic Syndrome on Long-term Renal Function in Patients Undergoing Elective Partial Nephrectomy for Small Renal MassesPietro Scilipoti, Giuseppe Rosiello, Federico Belladelli, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 1, 2025
Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelinesMattia Longoni, Giorgio Brembilla, Giuseppe Rosiello, et al.
Urologic Oncology|November 26, 2021
Simplified PADUA renal (SPARE) nephrometry score validation and long-term outcomes after robot-assisted partial nephrectomyGiuseppe Rosiello, Pietro Piazza, Stefano Puliatti, et al.
World Journal of Urology|October 12, 2022
Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicityGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
The Journal of Urology|November 28, 2022
Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell CarcinomaGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
BJU International|August 19, 2014
Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective studyAlberto Abrate, Massimo Lazzeri, Giovanni Lughezzani, et al.
Pageof 34